ASTM F3570-22 - Standard Terminology Relating to Microphysiological Systems
Standard Terminology Relating to Microphysiological Systems
|Keywords:||alternatives to animal models; biomedical research; body-on-a-chip; disease models; drug development; drug discovery; drug screen; drug studies; drug validation; ex vivo testing; in vitro/ex vivo drug screening system; in vitro/ex vivo physiology study system; in vitro testing; microphysiological model; microphysiological systems; multi-organs on a chip; organ-on-a-chip; organs-on-chips; pathophysiology studies; patient-speciﬁc testing; pharmacology testing; physiology studies; precision medicine; regenerative medicine; tissue-on-a-chip; toxicology;|
1.1 This terminology defines basic terms and presents the relationships of the scientific fields related to microphysiological systems (MPS). Committee F04 has defined these terms for the specific purpose of unifying the language used in standards for MPS.
1.2 The terms and nomenclature presented in this standard are for the speciﬁc purpose of unifying the language used in MPS standards and are not intended for labeling of regulated medical products.
1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.
1.4 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.